These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 8440099

  • 1. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group.
    Fisher CJ, Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, Harris SJ, Schein RM, Panacek EA, Vincent JL.
    Crit Care Med; 1993 Mar; 21(3):318-27. PubMed ID: 8440099
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.
    Reinhart K, Wiegand-Löhnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J.
    Crit Care Med; 1996 May; 24(5):733-42. PubMed ID: 8706447
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock.
    Boillot A, Capellier G, Racadot E, Wijdenes J, Herve P, Barale F.
    Clin Intensive Care; 1995 May; 6(2):52-6. PubMed ID: 10150799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.
    Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL.
    Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators.
    Marik PE, Zaloga GP, NORASEPT II Study Investigators. North American Sepsis Trial II.
    J Am Geriatr Soc; 2001 Jan; 49(1):5-9. PubMed ID: 11207836
    [Abstract] [Full Text] [Related]

  • 11. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
    Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S.
    Lancet; 1998 Mar 28; 351(9107):929-33. PubMed ID: 9734938
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG, Moura AD, Vieira ÉL, Pedroso ÊR, Teixeira AL.
    J Crit Care; 2015 Apr 28; 30(2):440.e7-13. PubMed ID: 25541104
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial.
    Clark MA, Plank LD, Connolly AB, Streat SJ, Hill AA, Gupta R, Monk DN, Shenkin A, Hill GL.
    Crit Care Med; 1998 Oct 28; 26(10):1650-9. PubMed ID: 9781721
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Observations on the role of tumor necrosis factor-alpha in a murine model of shock due to Streptococcus pyogenes.
    Wayte J, Silva AT, Krausz T, Cohen J.
    Crit Care Med; 1993 Aug 28; 21(8):1207-12. PubMed ID: 8339588
    [Abstract] [Full Text] [Related]

  • 20. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.
    Stack AM, Saladino RA, Thompson C, Sattler F, Weiner DL, Parsonnet J, Nariuchi H, Siber GR, Fleisher GR.
    Crit Care Med; 1995 Sep 28; 23(9):1512-8. PubMed ID: 7664553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.